APA (7th ed.) Citation

Hari V. Kalluri, Ryota Kikuchi, Sheryl Coppola, Jeffrey Schmidt, Mohamed‐Eslam F. Mohamed, Daniel A.J. Bow, & Ahmed H. Salem. (2021). Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study. Wiley.

Chicago Style (17th ed.) Citation

Hari V. Kalluri, Ryota Kikuchi, Sheryl Coppola, Jeffrey Schmidt, Mohamed‐Eslam F. Mohamed, Daniel A.J. Bow, and Ahmed H. Salem. Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study. Wiley, 2021.

MLA (9th ed.) Citation

Hari V. Kalluri, et al. Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study. Wiley, 2021.